About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.
minkabu the infonoid
(C) 2024 MINKABU THE INFONOID, Inc.
kabutan

Shionogi & Co.,Ltd.(4507) Summary

4507
TSE Prime
Shionogi & Co.,Ltd.
2,297.5
JPY
+100.5
(+4.57%)
Apr 10, 3:30 pm JST
15.65
USD
Apr 10, 2:30 am EDT
Result
PTS
outside of trading hours
Summary Chart Historical News Financial Result
PER
11.4
PBR
1.45
Yield
2.50%
Margin Trading Ratio
14.47
Stock Price
Apr 10, 2025
Opening Apr 10, 9:06 am
2,335.0 JPY 15.84 USD
Previous Close Apr 9
2,197.0 JPY 15.11 USD
High Apr 10, 9:06 am
2,342.0 JPY 15.88 USD
Low Apr 10, 12:34 pm
2,262.0 JPY 15.41 USD
Volume
3,701,300
Trading Value
8.48B JPY 0.06B USD
VWAP
2290.92 JPY 15.61 USD
Minimum Trading Value
229,750 JPY 1,565 USD
Market Cap
2.04T JPY 0.01T USD
Number of Trades
9,542
Liquidity & Number of Trades
As of Apr 10, 2025
Liquidity
High
1-Year Average
3,576
1-Year High Jun 7, 2024
25,920
Margin Trading
Date Short Interest Long Margin Positions Ratio
Apr 4, 2025 56,900 457,500 8.04
Mar 28, 2025 42,300 646,700 15.29
Mar 21, 2025 44,000 688,300 15.64
Mar 14, 2025 41,500 683,200 16.46
Mar 7, 2025 45,300 656,800 14.50
Company Profile
Shionogi & Co., Ltd. has seen significant growth in its anti-HIV drugs. The company has strengths in hyperlipidemia medications, pain management, and the infection field. It is also accelerating its expansion into overseas markets.
Sector
Pharmaceuticals
Shionogi & Co., Ltd. engages in the research and development, procurement, manufacturing, and sales of prescription pharmaceuticals, with a particular strength in the field of infectious diseases. The company has numerous subsidiaries and affiliated companies both domestically and internationally, enabling a global business operation. Key subsidiaries include Shionogi Pharma, which handles manufacturing and contract manufacturing; Shionogi Healthcare, which develops OTC pharmaceutical business; and Shionogi TechnoAdvance Research, which provides research support for drug discovery. Overseas, Shionogi has established bases primarily in the United States, as well as in Europe and Asia, to promote local research and development and sales activities. In China, in particular, the company operates through multiple subsidiaries, demonstrating its active pursuit of expansion into foreign markets.